Free Access
Issue
J Extra Corpor Technol
Volume 41, Number 2, June 2009
Page(s) 64 - 72
DOI https://doi.org/10.1051/ject/200941064
Published online 15 June 2009
  1. Baker RA, Willcox TW. Australian and New Zealand perfusion survey: Equipment and monitoring. J Extra Corpor Technol. 2006;38:220–9. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Wajon PR, Walsh RG, Symons NLP. A survey of cardiopulmonary bypass perfusion practices in Australia in 1992. Anaesth Intensive Care. 1993;21:814–21. [CrossRef] [PubMed] [Google Scholar]
  3. Jenkins OF, Morris M, Simpson JM. Australasian perfusion incident survey. Perfusion. 1997;12:279–88. [CrossRef] [PubMed] [Google Scholar]
  4. Silvay G, Ammar T, Reich DL, Vela-Cantos F, Joffe D, Ergin AM. Cardiopulmonary bypass for adult patients: A survey of equipment and techniques. J Cardiothorac Vasc Anesth. 1995;9:420–4. [CrossRef] [Google Scholar]
  5. Mejak BL, Stammers A, Rauch E, Vang A, Viessman T. A retrospective study on perfusion incidents and safety devices. Perfusion. 2000;15:51–61. [CrossRef] [PubMed] [Google Scholar]
  6. Stammers AH, Mejak BL. An update on perfusion safety: Does the type of perfusion practice affect the rate of incidents related to cardiopulmonary bypass? Perfusion. 2001;16:189–98. [CrossRef] [PubMed] [Google Scholar]
  7. Belway D, Rubens FD, Wozny D, Henley B, Natahn HJ. Are we doing everything we can to conserve blood during bypass? A national survey. Perfusion. 2005;20:237–41. [CrossRef] [PubMed] [Google Scholar]
  8. Charriere JM, Pelissie J, Verd C, et al. Survey: Retrospective survey of monitoring/safety devices and incidents of cardiopulmonary bypass for cardiac surgery in France. J Extra Corpor Technol. 2007;39:142–57. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. DioDato CP, Likosky DS, DeFoe GR, et al. Cardiopulmonary bypass recommendations in adults: The Northern New England experience. J Extra Corpor Technol. 2008;40:16–20. [Google Scholar]
  10. Nussmeier NA. Management of temperature during and after cardiac surgery. Tex Heart Inst J. 2005;32:472–6. [Google Scholar]
  11. Hogue CW, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes: An evidence-based appraisal of current practices. Anesth Analg. 2006;103:21–37. [CrossRef] [PubMed] [Google Scholar]
  12. Hartman G. Pro: During cardiopulmonary bypass for elective coronary artery bypass grafting, perfusion pressure should routinely be greater than 70 mmHg. J Cardiothorac Vasc Anesth. 1998;12:358–60. [CrossRef] [Google Scholar]
  13. Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass: A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995;110:1302–11. [CrossRef] [Google Scholar]
  14. Charlson ME, Peterson JC, Krieger KH, et al. Improvement of outcomes after coronary artery bypass II: A randomized trial comparing intraoperative high versus customized mean arterial pressure. J Card Surg. 2007;22:465–72. [CrossRef] [PubMed] [Google Scholar]
  15. Cartwright CR, Mangano CM. Con: During cardiopulmonary bypass for elective coronary artery bypass grafting, perfusion pressure should not routinely be greater than 70 mmHg. J Cardiothorac Vasc Anesth. 1998;12:361–4. [CrossRef] [Google Scholar]
  16. Anttila V, Hagino I, Zurakowski D, et al. Specific bypass condi tions determine safe minimum flow rate. Ann Thorac Surg. 2005;80:1460–7. [CrossRef] [Google Scholar]
  17. Murkin JM, Martzke JS, Buchan AM, Bentley C, Wong CJ. A randomized study of the influence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery. I. Mortality and cardiovascular morbidity. J Thorac Cardiovasc Surg. 1995;110:340–8. [CrossRef] [Google Scholar]
  18. Ji B, Undar A. An evaluation of the benefits of pulsatile versus non-pulsatile perfusion during cardiopulmonary bypass procedures in pediatric and adult cardiac patients. ASAIO J. 2006;52:357–61. [CrossRef] [PubMed] [Google Scholar]
  19. Undar A, Rosenberg G, Myers JL. Major factors in the controversy of pulsatile versus nonpulsatile flow during acute and chronic cardiac support. ASAIO J. 2005;51:173–5. [CrossRef] [PubMed] [Google Scholar]
  20. Guru V, Omura J, Alghamdu AA, Weisel R, Fremes SE. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation. 2006;114:I331–8. [CrossRef] [PubMed] [Google Scholar]
  21. Okamoto F, Allen BS, Buckberg GD, Young H, Bugyi H, Leaf J. Studies of controlled reperfusion after ischemia. XI: Reperfusate composition: Interaction of marked hyperglycemia and marked hyperosmolarity in allowing immediate contractile recovery after four hours of regional ischemia. J Thorac Cardiovasc Surg. 1986;92:583–93. [CrossRef] [Google Scholar]
  22. Shann KG, Likosky DS, Murkin JM, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283–90. [CrossRef] [Google Scholar]
  23. Edwards FH, Ferraris VA, Shahian DM, et al. Gender-specific practice guidelines for coronary artery bypass surgery: Perioperative management. Ann Thorac Surg. 2005;79:2189–94. [CrossRef] [Google Scholar]
  24. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;83:S27–86. [CrossRef] [Google Scholar]
  25. Rubens FD, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ. The cardiotomy trial: A randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation. 2007;116:I89–97. [CrossRef] [PubMed] [Google Scholar]
  26. Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007;297:471–9. [CrossRef] [PubMed] [Google Scholar]
  27. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319–31. [CrossRef] [PubMed] [Google Scholar]
  28. American Society of ExtraCorporeal Technology. AmSECT Guidelines for Perfusion Practice. Available at: www.amsect.org. Accessed May 21, 2008. [Google Scholar]
  29. American Academy of Cardiovascular Perfusion. Guidelines of Per fusion Practice: A Statement of The American Academy of Cardiovascular Perfusion. Available at: www.theaacp.com. Accessed May 21, 2008. [Google Scholar]
  30. Svenmarker S, Haggmark S, Jansson E, Lindholm R, Appelblad M, Aberg T. Quality assurance in clinical perfusion. Eur J Cardiothorac Surg. 1998;14:409–14. [CrossRef] [PubMed] [Google Scholar]
  31. Palanzo DA. Perfusion safety: Defining the problem. Perfusion. 2005;20:195–203. [CrossRef] [PubMed] [Google Scholar]
  32. Baker RA, Newland RF. Continuous quality improvement of perfusion practice:The role of electronic data collection and statistical control charts. Perfusion. 2008;23:7–16. [CrossRef] [PubMed] [Google Scholar]
  33. Newland R, Baker RA, Stanley R, Place K, Willcox TW. The Perfusion Downunder Collaborative Database project. J Extra Corpor Technol. 2008;40:159–65. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.